Immunovant (NASDAQ:IMVT) reported its Q3 earnings results on Monday, February 12, 2024 at 07:00 AM. Here’s what investors need to know about the announcement. EarningsImmunovant beat estimated earnings by 16.28%, reporting an EPS of $-0.36 versus an estimate of $-0.43. Revenue was down $0 from the same period last year. Past Earnings PerformanceLast quarter the company beat on EPS by $0.03 which was followed by a 4.22% increase in the share price the next day. To track all earnings releases for Immunovant visit their earnings calendar here. This article was generated by Benzinga’s automated co…